YOLFTbeta
Goodrx Holdings Inc

Goodrx Holdings Inc

GDRX · NASDAQ · Healthcare / Health Information Services

3.56USD+0.05 (+1.42%)

Price History

Full chart

Market Stats

Previous Close3.51
Open3.56
Day Range3.50 – 3.61
52-Week Range1.77 – 4.05
Volume787.75K
Market Cap1.22B
P/E (TTM)71.40
Forward P/E10.29
EPS0.05
Dividend Yield0.00%
Beta1.69
50-Day Avg3.45
200-Day Avg2.80

About

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMs. Wendy Barnes
  • Employees697
  • Headquarters2701 Olympic Boulevard, Santa Monica, CA, United States, 90404, USA
  • Websitehttps://www.goodrx.com

Leadership

  • Ms. Wendy BarnesPresident, CEO & Director · b. 1973
  • Mr. Douglas Joseph HirschCo-founder & Director · b. 1971
  • Mr. Justin FenglerChief Strategy & Operations Officer, CFO and Treasurer · b. 1988
  • Mr. Thomas ChanChief Accounting Officer & Principal Accounting · b. 1986
  • Mr. Nitin ShingateChief Technology Officer
  • Ms. Aubrey ReynoldsDirector of Investor Relations
  • Ms. Gracye ChengSenior VP, General Counsel & Secretary
  • Ms. Vina M. LeiteChief People Officer · b. 1970
  • Mr. Scott PaulSenior Vice President of Healthcare & Consumer Innovation
  • Mr. Aaron CrittendenChief Revenue Officer & President of Rx Marketplace

Financials

Income Statement

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue99.38M157.24M249.52M388.22M550.70M745.42M766.55M750.26M792.32M796.85M
Growth (%)-+58.23%+58.69%+55.59%+41.85%+35.36%+2.83%-2.12%+5.61%+0.57%
Cost of Revenue10.32M12.17M6.04M14.02M29.59M46.72M65.08M66.92M48.22M57.60M
Gross Profit89.06M145.07M243.49M374.21M521.11M698.71M701.48M683.34M744.11M739.26M
Gross Margin89.62%92.26%97.58%96.39%94.63%93.73%91.51%91.08%93.91%92.77%
Operating Expense70.14M94.76M166.24M234.53M796.83M685.30M699.74M710.35M678.26M651.76M
Operating Income18.92M50.31M77.25M139.68M-275.72M13.41M1.74M-27.01M65.85M87.49M
Operating Margin19.04%31.99%30.96%35.98%-50.07%1.80%0.23%-3.60%8.31%10.98%
EBITDA28.01M59.41M84.35M146.12M-257.11M48.00M65.19M108.82M153.92M184.36M
EBITDA Margin28.18%37.78%33.80%37.64%-46.69%6.44%8.50%14.50%19.43%23.14%
Net Income-7.77M8.84M43.79M66.05M-293.62M-25.25M-32.83M-8.87M16.39M30.44M
Net Income Margin-7.82%5.62%17.55%17.01%-53.32%-3.39%-4.28%-1.18%2.07%3.82%
R&D5.74M11.50M43.89M29.30M61.82M125.86M143.14M135.84M123.75M121.03M
R&D as % of Total Revenue5.78%7.31%17.59%7.55%11.22%16.88%18.67%18.11%15.62%15.19%
Interest Expense3.54M6.97M22.19M49.57M27.91M23.64M34.24M56.73M52.92M42.60M
Interest Expense % of Total Revenue3.56%4.43%8.89%12.77%5.07%3.17%4.47%7.56%6.68%5.35%

Balance Sheet

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets295.65M286.87M314.79M386.80M1.47B1.61B1.60B1.59B1.39B1.40B
Total Liabilities46.08M136.01M1.48B1.47B758.75M775.95M789.80M826.84M663.41M787.80M
Total Equity8.11M-86.19M-1.16B-1.09B711.36M831.68M814.83M761.96M724.66M616.26M
Cash23.61M17.54M34.60M26.05M968.69M941.11M757.16M672.30M448.35M261.82M
Total Debt46.08M136.01M722.24M710.99M704.92M702.33M717.02M711.07M543.39M542.81M
Net Debt22.47M118.47M687.64M684.94M-263.77M-238.78M-40.14M38.77M95.04M280.99M

Cash Flow

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow45.25M83.29M131.34M178.78M146.78M138.29M183.89M167.90M
Investing Cash Flow-3.46M-37.05M-91.62M-178.73M-210.50M-55.77M-70.35M-119.96M
Financing Cash Flow-24.73M-54.78M905.82M-30.53M-120.23M-167.40M-337.50M-234.47M
Capital Expenditure3.46M5.75M35.82M34.46M55.21M55.77M70.35M3.52M
Free Cash Flow41.80M77.54M95.52M144.32M91.57M82.53M113.55M164.38M
Dividends Paid1.35B078.71M22.67M-1--
FCF to OCF92.36%93.10%72.72%80.73%62.38%59.68%61.75%97.90%
Dividend Paid to FCF3221.33%0.00%82.41%15.71%-0.00%--

Earnings

Report DateAug 10, 2020Nov 12, 2020Mar 11, 2021May 13, 2021Aug 12, 2021Nov 10, 2021Feb 28, 2022May 9, 2022Aug 8, 2022Nov 8, 2022Feb 28, 2023May 10, 2023Aug 9, 2023Nov 9, 2023Feb 29, 2024May 9, 2024Aug 8, 2024Nov 7, 2024Feb 27, 2025May 7, 2025Aug 6, 2025Nov 4, 2025Feb 25, 2026May 6, 2026Aug 5, 2026Nov 3, 2026
EPS Estimate0.100.080.060.070.080.090.100.080.040.040.050.060.060.060.070.080.090.090.100.100.100.090.090.070.040.04
EPS Actual42.710.090.080.070.080.090.090.100.060.070.070.070.070.060.080.080.080.080.090.090.090.080.090.070.04-
Surprise42610.00%12.50%33.33%0.00%0.00%0.00%-10.00%25.00%50.00%75.00%40.00%16.67%16.67%0.00%14.29%0.00%-11.11%-11.11%-10.00%-5.96%-10.00%-11.11%-1.85%0.00%0.00%-
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap1.22B
Enterprise Value1.38B
Trailing P/E71.40
Forward P/E10.29
Price / Sales1.55
Price / Book1.75
EPS0.05
Book Value1.90
Revenue (TTM)785.23M
Gross Profit (TTM)713.19M
EBITDA108.78M
Profit Margin2.07%
Operating Margin11.79%
Return on Equity2.52%
Return on Assets3.05%
Shares Outstanding107.18M
Shares Float93.79M
Beta1.69
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Hold
Based on 14 analystsTarget 3.95
  • Strong Buy
    3
  • Buy
    1
  • Hold
    8
  • Sell
    2

Ownership Breakdown

Institutions
55.57%
Insiders
12.88%
Retail / Other
31.55%

Top Institutional Holders

  • Francisco Partners Management LP
    60.08M17.61%
  • LSV Asset Management
    5.16M1.51%
  • Ameriprise Financial Inc
    4.75M1.39%
  • Vanguard Capital Management, LLC
    4.09M1.20%
  • SILVER LAKE GROUP, L.L.C.
    3.53M1.04%
  • Renaissance Technologies Corp
    3.25M0.95%
  • Vanguard Portfolio Management, LLC
    3.21M0.94%
  • Petrus Trust Company, LTA
    3.10M0.91%
  • Dimensional Fund Advisors, Inc.
    2.56M0.75%
  • AQR Capital Management LLC
    2.33M0.68%
  • Jane Street Group LLC
    2.31M0.68%
  • Prescott Group Capital Management LLC
    2.11M0.62%
  • BlackRock Inc
    1.86M0.54%
  • Technology Crossover Management X, Ltd.
    1.65M0.48%
  • Geode Capital Management, LLC
    1.17M0.34%
  • Northern Trust Corp
    904.29K0.27%
  • Stifel Financial Corp
    868.79K0.25%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    2.93M0.86%
  • Vanguard Strategic Equity Inv
    1.26M0.37%
  • Vanguard Small Cap Index
    1.02M0.30%